Epidemiological evidence on multiple system atrophy

Journal of Neural Transmission

Volumn 112, Issue 12, 2005, Pages 1605-1612

  Vanacore, N ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Epidemiology; Multiple system atrophy

Indexed keywords

PESTICIDE;

AGRICULTURAL WORKER; AUTONOMIC NERVOUS SYSTEM; CLINICAL FEATURE; CONFERENCE PAPER; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; GENETIC ANALYSIS; HUMAN; MORBIDITY; OCCUPATIONAL HAZARD; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PYRAMIDAL SIGN; RISK ASSESSMENT; RISK FACTOR; SHY DRAGER SYNDROME;

ANIMALS; HUMANS; MULTIPLE SYSTEM ATROPHY; POLYMORPHISM, GENETIC;

EID: 27744516098     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-005-0380-7     Document Type: Conference Paper

References (41)

1. MCR Alavanja DP Sandler SB [tmp] McMaster SH Zahm CJ [tmp] McDonnell CF Lynch M Pennybacker N Rothman M Dosemeci AE Bond A Blair 1996 The agricultural health study. Env Health Perspect 104 362 369
2. O Bandmann GK Wenning N Quinn AE Harding 1995 Arg296 to Cys296 polymorphism in exon 6 of cytochrome P450IID6 (CYP2D6) is not associated with multiple system atrophy. J Neurol Neurosurg Psychiatry 59 257
3. Y Ben-Shlomo GK Wenning F Tison NP Quinn 1997 Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology 48 384 393
4. P Bennett V Bonifati U Bonuccelli C Colosimo M De Mari G Fabbrni R Marconi G Meco DJ Nicholl F Stocchi N Vanacore P Vioeregge AC Williams ESGAP Consortium 1998 Direct genetic evidence for involvement of tau in progressive supranuclear palsy. Neurology 51 982 985
5. V Bonifati BA Oostra P Heutink 2004 Unraveling the pathogenesis of Parkinson's disease - the contribution of monogenic forms. Cell Mol Life Sci 61 1729 1750
6. JH Bower DM Maraganore SK [tmp] McDonnell WA Rocca 1997 Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 49 1284 1288
7. NJ Cairns PF Atkinson T Kovacs AJ Lees SE Daniel PL Lantos 1997 Apolipoprotein E epsilon 4 allele frequency in patients with multiple system atrophy. Neurosci Lett 221 161 164
8. A Chio C Magnani D Schiffer 1998 Prevalence of Parkinson's disease in Northwestern Italy: comparison of tracer methodology and clinical ascertainment of cases. Mov Disord 13 400 405
9. S Cho CH Kin JF Cubelles CP Zabetian DY Hwang JW Kim BM Cohen I Biaggioni Robertson KS Kim 2003 Variations in the dopamine-β-hydroxylase gene are not associated with the autonomic disorders, pure autonomic failure or multiple system atrophy. Am J Med Genet 120A 234 236
10. V Chrysostome F Tison F Yekhlef C Sourgen I Baldi JF Datigues for the MSA-Aquitaine Network 2004 Epidemiology of Multiple System Atrophy: a prevalence and pilot risk factor study in Aquitaine, France. Neuroepidemiology 23 201 208
11. C Colosimo N Vanacore V Bonifati G Fabbrini A Rum G De Michele M De Mari U Bonuccelli DJ Nicholl G Meco European Study Group on Atypical Parkinsonism (ESGAP) Consortium 2001 Clinical diagnosis of multiple system atrophy: level of agreement between Quinn's criteria and the consensus conference guidelines. Acta Neurol Scand 103 261 264
12. MC de Rijk MM Breteler GA Graveland A Ott DE Grobbee FG van der Meche A Hofman 1995 Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology 45 2143 2146
13. H Frumkin 1998 Multiple system atrophy following chronic carbon disulfide exposure. Environ Health Perspect 106 611 613
14. S Garte L Gaspari AK Alexandrie C Ambrosone H Autrup JL Autrup H Baranova L Bathum S Benhamou P Boffetta C Bouchardy K Breskvar J Brockmoller I Cascorbi ML Clapper C Coutelle A Daly M Dell'Omo V Dolzan CM Dresler A Fryer A Haugen DW Hein A Hildesheim A Hirvonen LL Hsieh M Ingelman-Sundberg I Kalina D Kang M Kihara C Kiyohara P Kremers P Lazarus L Le Marchand MC Lechner EM van Lieshout S London JJ Manni CM Maugard S Morita V Nazar-Stewart K Noda Y Oda FF Parl R Pastorelli I Persson WH Peters A Rannug T Rebbeck A Risch L Roelandt M Romkes D Ryberg J Salagovic B Schoket J Seidegard PG Shields E Sim D Sinnet RC Strange I Stucker H Sugimura J To-Figueras P Vineis MC Yu E Taioli 2001 Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomark Prev 10 1239 1248
15. S Gilman PA Low N Quinn A Albanese Y Ben-Shlomo CJ Fowler H Kaufmann T Klockgether AE Lang PL Lantos I Litvan CJ Mathias E Oliver D Robertson I Schatz GK Wenning 1999 Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163 94 98
16. PA Hanna J Jankovic JB Kirkpatrick 1999 Multiple system atrophy. The putative causative role of environmental toxins. Arch Neurol 56 90 94
17. SJ Hwanh TH Beaty KY Liang J Coresh MJ Khoury 1994 Minimum sample size estimation to detect gene-environment interaction in case-control designs. Am J Epidemiol 140 1029 1037
18. H Hashoda J Goto N Hao N Takahashi M Hirai I Kanazawa Y Sakaki 1998 Cloning and mapping of ZNF231, anovel brain-specific gene encoding neuronal double zinc finger protein whose expression is enhanced in a neurodegenerative disorder, multiple system atrophy (MSA). Genomics 54 50 58
19. J Infante J Llorca J Berciano O Combarros 2005 Interleukin-8, intercellular adhesion molecule-1 and tumour necrosis factor-alpha gene polymorphisms and the risk for multiple system atrophy. J Neurol Sci 228 11 13
20. K Iwahashi R Miyataake Y Tsuneoka Y Matsuo Y Ichikawa K Hosokawa K Sato T Hayabara 1995 A novel cytochrome P450IID6 (CYPIID6) mutant gene associated with multiple system atrophy. J Neurol Neurosurg Psychatry 58 263
21. MS Lee CH Lyoo I Ulmanen AC Syvanen JO Rinne 2001 Genotypes of cathecol-O-methyltransferase and response to levodopa treatment in patients with Parkinson's disease. Neurosci Lett 298 131 134
22. MacMahon B, Pugh TF (1970) Epidemiology: principles and methods. Little, Brown, Boston
23. HR Morris A Scxhrag U Nath D Burn NP Quinn S Daniel NW Wood AJ Lees 2001 Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy. Neurosci Lett 312 118 120
24. N Nakao O Brundin 1997 Effects of a-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid. Neuroscience 76 749 761
25. LE Nee M Gomez J Dambrosia S Bale R Eldridge RJ Polinsky 1991 Environmental-occupational risk factors in multiple system atrophy: a preliminary investigation. Clin Auton Res 1 9 13
26. DJ Nicholl P Bennett L Hiller V Bonifati N Vanacore G Fabbrini R Marconi C Colosimo P Lamberti F Stocchi U Bonuccelli P Vieregge DB Ramsden G Meco AC Williams 1999 A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology 53 1415 1421
27. M Nishimura H Kawakami O Komure H Maruyama H Morino Y Izumi S Nakamura R Kaji S Kuno 2002 Contribution of the interleukin-1beta gene polymorphism in multiple system atrophy. Mov Disord 17 808 811
28. M Nishimura S Kuno R Kaji H Kawakami 2005 Influence of a tumor necrosis factor gene polymorphism in Japanese patients with multiple system atrophy. Neurosci Lett 374 218 221
29. V Plantè-Bordeneuve O Bandmann G Wenning NP Quinn SE Daniel AE Harding 1995 CYP2D6 debrisoquine hydroxylase gene polymorphism in multiple system atrophy. Mov Disord 10 277 278
30. Quinn N (1989) Multiple system atrophy - the nature of the beast. J Neurol Neurosurg Psychiatry (Suppl): 78-89
31. JA Schneider M Gearing RS Robbins W De L'Aune SS Mirra 1995 Apolipoprotein E genotype in diverse neurodegenerative diseases. Ann Neurol 38 131 135
32. A Schrag Y Ben-Shlomo NP Quinn 1999 Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 354 1771 1775
33. EK Tan Y Zhao KY Puong HY Law LL Chan K Yew C Tan H Shen VR Chandran ML Teoh Y Yih R Pavanni MC Wong IS Ng 2004 Fragile X premutation alleles in SCA, ET, and parkinsonism in an Asian cohort. Neurology 63 362 363
34. C Trenkwalder J Schwarz J Gebhard D Ruland P Trenkwalder HW Hense WH Oertel 1995 Starnberg trial on epidemiology of Parkinsonism and hypertension in the elderly. Prevalence of Parkinson's disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years. Arch Neurol 52 1017 1022
35. N Vanacore V Bonifati G Fabbrini C Colosimo G De Michele R Marconi F Stocchi D Nicholl U Bonuccelli M De Mari P Vieregge G Meco and the ESGAP Consortium 2005 A case-control study on multiple system atrophy. Mov Disord 20 158 163
36. N Vanacore V Bonifati G Fabbrini C Colosimo R Marconi D Nicholl U Bonuccelli F Stocchi P Lamberti G Volpe G De Michele I Iavarone P Bennet P Vieregge G Meco and the European Study Group on Atypical Parkinsonisms 2000 Smoking habits in multiple system atrophy and progressive supranuclear palsy. Neurology 54 114 119
37. H Watanabe Y Saito S Terao T Ando T Kachi E Mukai I Aiba Y Abe A Tamakoshi M Doyu M Hirayaman G Sobue 2002 Progression and prognosis in multiple system atrophy. An analysis of 230 Japanese patients. Brain 125 1070 1083
38. GK Wenning S Wagner S Daniel NP Quinn 1993 Multiple system atrophy: sporadic or familial? Lancet 342 681
39. L Wermuth P Joensen N Bunger B Jeune 1997 High prevalence of Parkinson's disease in the Faroe Islands. Neurology 49 426 432
40. U Wullner M Abele T Schmitz-Huebsch K Wilhelm R Benecke G Deuschl T Klockgether 2004 Probable multiple system atrophy in a German family. J Neurol Neurosurg Psychiatry 75 924 925
41. KT Zondervan LR Cardon 2004 The complex interplay among factors that influence allelic association. Nat Rev Genet 5 89 100